GENE On Other Exchanges
Symbol
Exchange
OTC US
NASDAQ CM
Frankfurt
text size: T | T
Back to Snapshot
Company Description

Contact Info

60-66 Hanover Street

Fitzroy, VIC 3065

Australia

Phone: 61 3 8412 7000

Fax: 61 3 8412 7040

Genetic Technologies Limited operates as a molecular diagnostics company that offers predictive testing and assessment tools to help physicians manage women’s health. The company’s lead product, BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. BREVAGenplus improves upon the predictive power of the first generation BREVAGen test and is designed to facilitate better informed decisions about breast cancer screening and preventive treatment plans. BREVAGenplus expands the application of BREVAGen from Caucasian women to include African-Americans and Hispanics, and is directed towards women aged 35 years or above, who have not had breast cancer and have one or more risk factors for developing breast cancer. The company has launched the first generation BREVAGen test across the U.S. via its U.S. subsidiary Phenogen Sciences Inc. and the addition of BREVAGenplus, launched in October 2014. The Company markets BREVAGenplus to healthcare professionals in comprehensive breast health care and imaging centres, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists (such as breast surgeons). Strategy As part of the company’s strategy to focus on the expansion of its cancer diagnostic franchise, the company continues to evaluate opportunities to sell, out-license or co-develop other assets and technologies in which the company has an interest, including its legacy non-coding assertion and licensing program. Environmental Regulations The company’s operations are subject to environmental regulations under Australian State legislation. In particular, the company is subject to the requirements of the Environment Protection Act 1993. History Genetic Technologies Limited was founded in 1989.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

GENE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GENE.
View Industry Companies
 

Industry Analysis

GENE

Industry Average

Valuation GENE Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 27.1x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 13.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact GENETIC TECH LTD-SP ADR, please visit www.gtglabs.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.